SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : IBIS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sixty2nds who wrote (293)2/8/2005 11:27:13 AM
From: sixty2nds   of 301
 
07 Feb 15:12


By Deborah Finestone
Of DOW JONES NEWSWIRES

NEW YORK (Dow Jones)--Shares of Ibis Technology Corp. (IBIS) jumped 20%
Monday on talk that the semiconductor wafer maker would benefit from the newly
announced "Cell" chip from International Business Machines Corp. (IBM), Sony
Corp. (SNE) and Toshiba Corp. (6502.TO).

Ibis has made no announcements to account for the rise in the share price,
said spokesman Bill Schmidt. As for the chip, Schmidt said, Ibis is always in
discussions with manufacturers, but has said nothing to indicate any kind of
agreement dealing with the Cell chip.

"But that should have some promise," he said about the talks.

The new breed of computer chip, dubbed Cell, is designed to supercharge
digital media and computer graphics. Cell is being targeted for use in Sony's
next videogame machine - expected as early as 2006 - and digital TVs and DVD
players, according to The Wall Street Journal. But the technology also is
expected to be adapted for products ranging from high-performance computers to
cellphones.

The prototype chip is fabricated with 90-nanometer silicon-on-insulator
technology, according to a joint press release from IBM, Sony and Toshiba on
Monday. Initial production of the Cell microprocessors is expected to begin
this year at IBM's wafer fabrication facility in East Fishkill, N.Y., followed
by Sony's Nagasaki, Japan, facility.

Ibis uses a technique for manufacturing SOI wafers called separation by
implantation of oxygen, or Simox, where an oxygen implanter creates a very thin
insulating layer within the wafer, just below a thin layer of silicon on the
top of the wafer.

The new Cell chip "may be good news for us because we're an equipment
manufacturer that ultimately sells the equipment to produce that wafer - if it
uses Simox," Schmidt said. "People could be speculating this will have a major
impact on our equipment business."
An analyst who used to cover Ibis also cited the IBM-Sony-Toshiba
announcement as a possible reason for the price movement.

Officials at IBM did not immediately return calls seeking comment. Sony and
Toshiba representatives couldn't be reached.

Shares of Ibis recently traded at $3.36, up 56 cents, or 20%, on volume of
1.2 million. The average daily volume is 264,800 shares.

-By Deborah Finestone, Dow Jones Newswires; 201-938-2205

(END) Dow Jones Newswires
02-07-05 1512ET
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext